Literature and evidence database
Find the source, the model and the boundary.
Search source records connected to the product-family knowledge base. Filter by category, product, publication year, research type, study model and editorial evidence tier.
Product evidence maps
A focused source set for each product.
Search and filter
Evidence records
Narrow the records by product, year or study model. Open each source to check its results and limitations.
Certain Bulk Drug Substances That May Present Significant Safety Risks
U.S. FDA. Current compounding safety-information page.
Care and handling of peptides
Care and handling of peptides
Targeted delivery of antimicrobial peptide LL-37 via ferritin fusion improves antibacterial and anti-inflammatory outcomes in a murine sepsis model.
Targeted delivery of antimicrobial peptide LL-37 via ferritin fusion improves antibacterial and anti-inflammatory outcomes in a murine sepsis model.
Coordination chemistry and antimicrobial activity of LL-37, its C-terminal fragment, and a peptidomimetic analogue.
Coordination chemistry and antimicrobial activity of LL-37, its C-terminal fragment, and a peptidomimetic analogue.
KPV attenuates adipogenesis and lipid metabolism through modulation of ROS-mediated AKT/mTORC1/PPARγ signaling.
KPV attenuates adipogenesis and lipid metabolism through modulation of ROS-mediated AKT/mTORC1/PPARγ signaling.
Peptide Isolation – Method Development Considerations
Peptide Isolation – Method Development Considerations
LL-37 analog activity, cytotoxicity and serum inhibition
In-vitro context; PMID 15980359.
Solubility Guidelines for Peptides
Solubility Guidelines for Peptides
LL-37, self-DNA and plasmacytoid dendritic cells
LL-37, self-DNA and plasmacytoid dendritic cells
Role of DNA-LL37 complexes in the activation of plasmacytoid dendritic cells and monocytes in subjects with type 1 diabetes
Role of DNA-LL37 complexes in the activation of plasmacytoid dendritic cells and monocytes in subjects with type 1 diabetes
ICH Q2(R2): Validation of Analytical Procedures
Defines validation characteristics and distinguishes quantitative analytical purposes.
Cell components: amino acids and peptide bonds
Cell components: amino acids and peptide bonds
Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37
Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37
Research news reference — pubmed.ncbi.nlm.nih.gov — news-23
Research news reference — pubmed.ncbi.nlm.nih.gov — news-22
Research news reference — pubmed.ncbi.nlm.nih.gov — news-21
Research news reference — pubmed.ncbi.nlm.nih.gov — news-20
Research news reference — pubmed.ncbi.nlm.nih.gov — news-19
Research news reference — pubmed.ncbi.nlm.nih.gov — news-18
Primary publication — PubMed 39211778
Primary publication — PubMed 26056426
Primary publication — PubMed 34687253
ICH Q2(R2) Validation of Analytical Procedures
ICH Q2(R2) Validation of Analytical Procedures
Editorial methodology
How records are classified
Records are deduplicated by source URL and linked to every relevant product family. Study type and model are inferred from the citation and editorial evidence label, then reviewed during content QA.
Read the full editorial, AI-assistance and correction policy →
Labels and databases supporting regulatory status, formulation or chemical identity.
Controlled trials, systematic reviews and other clinical records with population-specific interpretation.
Animal, cell, analytical and mechanistic records that cannot establish human outcomes.
Narrative reviews, registries and sponsor reports kept visibly distinct from peer-reviewed outcomes.
Use the records
